摘要: |
[目的]构建pCDNA3.1-Annexin A7载体并稳定转染Hca-p细胞。[方法]提取小鼠总RNA,逆转录成cDNA,PCR扩增,获取Annexin A7 CDS,将PcDNA3.1(+)质粒和Annexin A7 CDS片段行BamH I和 EcoR I双酶切,构建并抽提pCDNA3.1- Annexin A7质粒,测序鉴定后转染Hca-p细胞,经400 μg/mL G418 完全培养基筛选获得pCDNA3.1- Annexin A7载体稳定转染的Hca-p细胞,在蛋白质水平检验Annexin A7的表达并行基因组DNA鉴定。[结果]成功构建pCDNA3.1- Annexin A7载体,经测序鉴定,所得到的载体中的CDS经比对与库中序列一致。pCDNA3.1- Annexin A7载体转染Hca-p细胞后,获得稳定上调表达Annexin A7的Hca-p细胞株; 行基因组DNA鉴定,证实pCDNA3.1- Annexin A7已转入Hca-P细胞中, western-blotting 结果显示转染前后蛋白的表达相对值Annexin A7/GAPDH分别为0.43544±0.0112和0.45957±0.0065 (P<0.05)。[结论]pCDNA3.1-Annexin A7的构建并稳定转染Hca-p细胞成功,为通过上调Annexin A7在Hca-P的表达以证实Annexin A7与恶性肿瘤淋巴道转移潜能关系的相关研究打下了基础。 |
关键词: 膜联蛋白A7 PCR 转染 肿瘤 淋巴道转移 |
DOI:10.11724/jdmu.2008.04.02 |
分类号:R 73 |
基金项目: |
|
Construction of pCDNA3.1-Annexin A7 and expression in Hca-p |
WANG Zhi-qiang1, TANG Jian-wu2,3, WANG Shao-qing2,3, SUN Cheng-rong1, WANG Bo2,3
|
1.Department of Otorhinolaryngology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011,China;2.Department of Pathology,Dalian Medical University, Dalian 116044,China;3. Department of Oncology,the 5th Hospital of Dalian City, Dalian 116021,China
|
Abstract: |
[Objective]To construct pCDNA3.1- Annexin A7 and to transfectant it the Hca-P stably.[Methods]The Annexin A7 gene was amplified by PCR. BamH I and EcoR I enzyme were used to digest the Annexin A7 gene and PcDNA3.1 plasmid. The pCDNA3.1- Annexin A7 were constructed to transfectant to the Hca-P stably.The effection of transfectanting was detected by genome DNA checkup and Western-blotting.[Results]The DNA sequencing result showed that the pCDNA3.1- Annexin A7 was constructed successfully, Genome DNA checkup demonstrated that the Hca-P were transfectanted by the pCDNA3.1- Annexin A7 stably, Western-blotting indicated that the value of optical density Annexin A7/GAPDH in transfectanted Hca-P was significantly higher than that in normal Hca-P (0.43544 0.0112 vs 0.45957±0.0065, P<0.05).[Conclusions]pCDNA3.1-annexin A7 was constructed and transfectanted to the Hca-P successfully. |
Key words: annexin A7 PCR transfection hepatocarciroma |